Sasha Keough
@Sr One Capital Management, Lp
Latest period2024 - Q3ReportedManaged Assets$498.735MTotal holdings11
Assets growth rate56.15%Assets growth rate (2-Q avg)21.94%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Sr One Capital Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 11 positions.
Assets under management
The assets under management (AUM) of Sr One Capital Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 498.735M in assets, with a quarterly growth rate of 56.15% and a 2-quarter average growth rate of 21.94%. The portfolio is managed by Sasha Keough, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ACLXArcellx, Inc.
| 39.3% | $195.967M 2.347M shares@ $83.51 avg price | |
ZBIOZenas Biopharma, Inc
| 16.67% | $83.103M 4.912M shares@ $16.93 avg price | New Position |
SPRYArs Pharmaceuticals, Inc.
| 11.67% | $58.187M 4.013M shares@ $14.51 avg price | |
CRSPCrispr Therapeutics Ag
| 9.89% | $49.28M 1.049M shares@ $46.99 avg price | |
DSGNDesign Therapeutics, Inc.
| 7.05% | $35.112M 6.526M shares@ $5.39 avg price | |
MLYSMineralys Therapeutics Inc.
| 4.9% | $24.424M 2.017M shares@ $12.11 avg price | |
ALMSAlumis Inc.
| 4.2% | $20.932M 1.96M shares@ $10.68 avg price | |
NKTXNkarta, Inc.
| 3.03% | $15.067M 3.333M shares@ $4.52 avg price | |
ORKAOruka Therapeutics, Inc
| 1.85% | $9.199M 375,330 shares@ $24.51 avg price | New Position |
ENGNEngene Holdings Inc.
| 0.99% | $4.935M 747,750 shares@ $6.6 avg price | Increased 49.55% |